natgillin/translations-raw huggingface dataset:
6.1 List of excipients sorbitol, propylene glycol, sucralose E 955, hypromellose 2910, sodium citrate dihydrate, natural and artificial flavour (bubblegum), citric acid anhydrous, disodium edetate, purified water 
6.1 Seznam pomožnih snovi sorbitol, propilenglikol, sukraloza E 955, hipromeloza 2910, natrijev citrat dihidrat, naravna in umetna aroma (žvečilni gumi), brezvodna citronska kislina, dinatrijev edetat, prečiščena voda
In single-dose crossover studies of Azomyr 5 mg orodispersible tablets with Azomyr 5 mg conventional tablets, the formulations were bioequivalent. 
V navzkrižnih študijah primerjave enkratnega odmerka zdravila Azomyr 5 mg orodisperzibilne tablete z zdravilom Azomyr 5 mg tablete sta se ti dve formulaciji izkazali za bioekvivalentni.
What Azomyr orodispersible tablet is and what it is used for What you need to know before you take Azomyr orodispersible tablet How to take Azomyr orodispersible tablet Possible side effects 
Kaj je zdravilo Azomyr orodisperzibilna tableta in za kaj jo uporabljamo Kaj morate vedeti, preden boste vzeli zdravilo Azomyr orodisperzibilna tableta Kako jemati zdravilo Azomyr orodisperzibilna tableta Možni neželeni učinki
When Azomyr should be used 
Kdaj je treba uporabljati zdravilo Azomyr
EU/1/00/157/059 30 ml with 1 spoon EU/1/00/157/060 50 ml with 1 spoon EU/1/00/157/061 60 ml with 1 spoon EU/1/00/157/062 100 ml with 1 spoon EU/1/00/157/063 120 ml with 1 spoon EU/1/00/157/064 150 ml with 1 spoon EU/1/00/157/067 150 ml with 1 oral syringe EU/1/00/157/065 225 ml with 1 spoon EU/1/00/157/066 300 ml with 1 spoon 
EU/1/00/157/059 30 ml z 1 odmerno žličko EU/1/00/157/060 50 ml z 1 odmerno žličko EU/1/00/157/061 60 ml z 1 odmerno žličko EU/1/00/157/062 100 ml z 1 odmerno žličko EU/1/00/157/063 120 ml z 1 odmerno žličko EU/1/00/157/064 150 ml z 1 odmerno žličko EU/1/00/157/067 150 ml z 1 odmerno brizgo za peroralno dajanje EU/1/00/157/065 225 ml z 1 odmerno žličko EU/1/00/157/066 300 ml z 1 odmerno žličko
What Azomyr is and what it is used for 
Kaj je zdravilo Azomyr in za kaj ga uporabljamo
What Azomyr orodispersible tablet is and what it is used for 
Kaj je zdravilo Azomyr orodisperzibilna tableta in za kaj ga uporabljamo
What you need to know before you take Azomyr orodispersible tablet 
Kaj morate vedeti, preden boste vzeli zdravilo Azomyr orodisperzibilna tableta
Azomyr 5 mg film-coated tablets are packed in blisters in packs of 1, 2, 3, 5, 7, 10, 14, 15, 20, 21, 30, 50 or 100 tablets. 
5 mg filmsko obložene tablete Azomyr so na voljo v pretisnih omotih po 1, 2, 3, 5, 7, 10, 14, 15, 20, 21, 30, 50 ali 100 tablet.
If you take more Azomyr oral solution than you should Take Azomyr oral solution only as it is prescribed for you. 
Če ste vzeli večji odmerek zdravila Azomyr, kot bi smeli Zdravilo Azomyr jemljite le tako, kot vam je bilo predpisano.
Azomyr orodispersible tablets are supplied in unit dose blisters comprised of laminate blister film with foil lidding. 
Azomyr orodisperzibilne tablete so na voljo v laminatnih pretisnih omotih za enojni odmerek, ki ga sestavljata film pretisnega omota in folija ki ga prekriva.
If you take more Azomyr orodispersible tablet than you should Take Azomyr orodispersible tablet only as prescribed for you. 
Če ste vzeli večji odmerek zdravila Azomyr orodisperzibilna tableta, kot bi smeli Zdravilo Azomyr orodisperzibilno tableto jemljite le tako, kot vam je bilo predpisano.
If you stop taking Azomyr orodispersible tablet If you have any further questions on the use of this medicine, ask your doctor, pharmacist or nurse. 
Če ste prenehali jemati zdravilo Azomyr orodisperzibilna tableta Če imate dodatna vprašanja o uporabi zdravila, se posvetujte z zdravnikom, farmacevtom ali medicinsko sestro.
Children 6 through 11 years of age: 5 ml (2.5 mg) Azomyr oral solution once a day. 
Otroci v starosti od 6 do 11 let: 5 ml (2,5 mg) peroralne raztopine Azomyr enkrat na dan.
Adults and adolescents (12 years of age and over) The recommended dose of Azomyr is two 2.5 mg orodispersible tablets placed in the mouth once a day. 
Odrasli in mladostniki (stari 12 let ali več) Priporočeni odmerek zdravila Azomyr sta dve 2,5 mg orodisperzibilni tableti v usta enkrat na dan.
Regarding the duration of treatment, your physician will determine the type of allergic rhinitis you are suffering from and will determine for how long you should take Azomyr orodispersible tablets. 
Kar zadeva trajanje zdravljenja, bo vaš zdravnik najprej ugotovil vrsto alergijskega rinitisa, ki jo imate, in na podlagi tega določil, kako dolgo naj bi jemali zdravilo Azomyr orodisperzibilna tableta.
Azomyr with food, drink and alcohol Azomyr may be taken with or without a meal. 
Zdravilo Azomyr skupaj s hrano, pijačo in alkoholom Zdravilo Azomyr se lahko jemlje s hrano ali brez nje.
At the recommended dose, Azomyr 5 mg orodispersible tablet was found to be bioequivalent to the Azomyr 5 mg conventional tablet formulation of desloratadine. 
Ugotovili so, da je zdravilo Azomyr orodisperzibilna tableta v priporočenem odmerku 5 mg bioekvivalentno običajni formulaciji desloratadina v obliki zdravila Azomyr 5 mg tablete.
Azomyr is indicated in adults, adolescents aged 12 years and older and children aged 6 - 11 years old for the relief of symptoms associated with: - allergic rhinitis (see section 5.1) - urticaria (see section 5.1) 
Zdravilo Azomyr je indicirano pri odraslih, mladostnikih, starih 12 let in več, in otrocih, starih 6 - 11 let, za lajšanje simptomov: - alergijskega rinitisa (glejte poglavje 5.1) - urtikarije (glejte poglavje 5.1)
If you stop taking Azomyr oral solution If you have any further questions on the use of this medicine, ask your doctor, pharmacist or nurse. 
Če ste prenehali jemati zdravilo Azomyr peroralna raztopina Če imate dodatna vprašanja o uporabi zdravila, se posvetujte z zdravnikom, farmacevtom ali medicinsko sestro.
Azomyr orodispersible tablet is an antiallergy medicine that does not make you drowsy. 
Zdravilo Azomyr orodisperzibilna tableta je zdravilo proti alergiji, ki ne povzroča zaspanosti.
What you need to know before you take Azomyr 
Kaj morate vedeti, preden boste vzeli zdravilo Azomyr
Use caution when taking Azomyr with alcohol. 
Pri sočasnem jemanju zdravila Azomyr in uživanju alkohola je potrebna previdnost.
How to store Azomyr orodispersible tablet Contents of the pack and other information 
Shranjevanje zdravila Azomyr orodisperzibilna tableta Vsebina pakiranja in dodatne informacije
Adverse reactions seen with Azomyr 
Neželeni učinki opaženi pri zdravilu Azomyr
Azomyr is indicated in adults, adolescents and children over the age of 1 year for the relief of symptoms associated with: - allergic rhinitis (see section 5.1) - urticaria (see section 5.1) 
Zdravilo Azomyr je indicirano pri odraslih, mladostnikih in otrocih, starejših od 1 leta, za lajšanje simptomov: - alergijskega rinitisa (glejte poglavje 5.1) - urtikarije (glejte poglavje 5.1)
In a clinical pharmacology trial, in adults and adolescents, in which desloratadine was administered to adults at a dose of 45 mg daily (nine times the clinical dose) for ten days, no prolongation of QTc interval was seen. 
V drugem kliničnem farmakološkem preskušanju pri odraslih in mladostnikih, pri katerem so odrasli jemali desloratadin v odmerku 45 mg na dan (9-kratni klinični odmerek) 10 dni, niso opažali podaljšanja intervala QTc.
Regarding the duration of treatment, your physician will determine the type of allergic rhinitis you are suffering from and will determine for how long you should take Azomyr. 
Kar zadeva trajanje zdravljenja, bo vaš zdravnik najprej ugotovil vrsto alergijskega rinitisa, ki jo imate, in na podlagi tega določil, kako dolgo naj bi jemali zdravilo Azomyr.
Azomyr contains lactose 
Zdravilo Azomyr vsebuje laktozo
Azomyr oral solution with food, drink and alcohol Azomyr may be taken with or without a meal. 
Zdravilo Azomyr peroralna raztopina skupaj s hrano, pijačo in alkoholom Zdravilo Azomyr se lahko jemlje s hrano ali brez nje.
Azomyr was effective in alleviating the burden of seasonal allergic rhinitis as shown by the total score of the rhino-conjunctivitis quality of life questionnaire. 
Zdravilo Azomyr je učinkovito ublažilo težave, povezane s sezonskim alergijskim rinitisom, kar so pokazali skupni rezultati vprašalnika o kakovosti življenja bolnikov z rinitisom in konjunktivitisom.
- The active substance is desloratadine 0.5 mg/ml - The other ingredients of the oral solution are sorbitol, propylene glycol, sucralose E 955, hypromellose 2910, sodium citrate dihydrate, natural and artificial flavour (bubblegum), citric acid anhydrous, disodium edetate and purified water. 
- Zdravilna učinkovina je desloratadin 0,5 mg/ml - Pomožne snovi v peroralni raztopini so sorbitol, propilenglikol, sukraloza E 955, hipromeloza 2910, natrijev citrat dihidrat, naravna in umetna aroma (žvečilni gumi), brezvodna citronska kislina, dinatrijev edetat in prečiščena voda.
Azomyr 0.5 mg/ml oral solution desloratadine 
Azomyr 0,5 mg/ml peroralna raztopina desloratadin
Azomyr is supplied in blisters comprised of laminate blister film with foil lidding. 
Azomyr je na voljo v laminatnih pretisnih omotih, ki ga sestavljata film pretisnega, omota in folija, ki ga prekriva.
Azomyr orodispersible tablet is also used to relieve the symptoms associated with urticaria (a skin condition caused by an allergy). 
Zdravilo Azomyr orodisperzibilna tableta se uporablja tudi za lajšanje simptomov urtikarije (težave s kožo zaradi alergije).
Azomyr oral solution contains sorbitol. 
Zdravilo Azomyr peroralna raztopina vsebuje sorbitol Azomyr peroralna raztopina vsebuje sorbitol.
Azomyr is indicated in adults and adolescents aged 12 years and older for the relief of symptoms associated with: - allergic rhinitis (see section 5.1) - urticaria (see section 5.1) 
Zdravilo Azomyr je indicirano pri odraslih in mladostnikih, starih 12 let in več, za lajšanje simptomov: - alergijskega rinitisa (glejte poglavje 5.1) - urtikarije (glejte poglavje 5.1)
Azomyr tablets given at a single daily dose of 7.5 mg to adults and adolescents did not affect psychomotor performance in clinical trials. 
V kliničnih preskušanjih zdravilo Azomyr v enem dnevnem odmerku 7,5 mg pri odraslih in mladostnikih ni vplivalo na psihomotorične sposobnosti bolnikov.
How to take Azomyr orodispersible tablet 
Kako jemati zdravilo Azomyr orodisperzibilna tableta
Azomyr orodispersible tablet is packed in unit dose blisters in packs of 5, 6, 10, 12, 15, 18, 20, 30, 50, 60, 90 and 100 doses of orodispersible tablet. 
Azomyr orodisperzibilne tablete so na voljo v pretisnih omotih po 5, 6, 10, 12, 15, 18, 20, 30, 50, 60, 90 in 100 orodisperzibilnih tablet.
In clinical trials in a range of indications including allergic rhinitis and chronic idiopathic urticaria, at the recommended dose of 5 mg daily, undesirable effects with Azomyr tablets were reported in 3 % of patients in excess of those treated with placebo. 
V kliničnih preskušanjih pri različnih indikacijah za uporabo zdravila, vključno z alergijskim rinitisom in kronično idiopatsko urtikarijo, so pri priporočenem odmerku 5 mg na dan o neželenih učinkih tablet Azomyr poročali pri 3 % bolnikov več kot pri tistih, ki so bili zdravljeni s placebom.
The safety and efficacy of Azomyr 5 mg film-coated tablets in children below the age of 12 years have not been established. 
Varnost in učinkovitost zdravila Azomyr 5 mg filmsko obložene tablete pri otrocih, mlajših od 12 let, nista bili dokazani.
In a multiple dose clinical trial, in adults and adolescents, in which up to 20 mg of desloratadine was administered daily for 14 days, no statistically or clinically relevant cardiovascular effect was observed. 
V kliničnem preskušanju večkratnega odmerjanja zdravila pri odraslih in mladostnikih, pri katerem so preiskovanci prejemali do 20 mg desloratadina na dan v času 14 dni, niso opažali nobenih statistično značilnih ali klinično pomembnih učinkov tega zdravila na srce ali ožilje.
The safety and efficacy of Azomyr 2.5 mg orodispersible tablets in children below the age of 6 years have not been established. 
Varnost in učinkovitost zdravila Azomyr 2,5 mg orodisperzibilne tablete pri otrocih, mlajših od 6 let, nista bili dokazani.
At the recommended dose, in clinical trials involving adults and adolescents in a range of indications including allergic rhinitis and chronic idiopathic urticaria, undesirable effects with Azomyr were reported in 3 % of patients in excess of those treated with placebo. 
V kliničnih preskušanjih pri odraslih in mladostnikih za različne indikacije, vključno z alergijskim rinitisom in kronično idiopatsko urtikarijo, so pri priporočenem odmerku o neželenih učinkih zdravila Azomyr poročali pri 3 % bolnikov več kot pri tistih, ki so bili zdravljeni s placebom.
In adult and adolescent patients with allergic rhinitis, Azomyr tablets were effective in relieving symptoms such as sneezing, nasal discharge and itching, as well as ocular itching, tearing and redness, and itching of palate. 
Pri odraslih in mladostnikih z alergijskim rinitisom zdravilo Azomyr tablete učinkovito lajša simptome, kakor so kihanje, iztok iz nosa in srbenje, pa tudi srbenje oči, solzenje in vnetje očesne veznice ter srbenje ustnega neba.
The safety and efficacy of Azomyr 0.5 mg/ml oral solution in children below the age of 1 year have not been established. 
Varnost in učinkovitost zdravila Azomyr 0,5 mg/ml peroralna raztopina pri otrocih, mlajših od 1 leta, nista bili dokazani.
What Azomyr oral solution is and what it is used for What you need to know before you take Azomyr oral solution How to take Azomyr oral solution Possible side effects 
Kaj je zdravilo Azomyr in za kaj ga uporabljamo Kaj morate vedeti, preden boste vzeli zdravilo Azomyr Kako jemati zdravilo Azomyr Možni neželeni učinki
In clinical trials in a range of indications including allergic rhinitis and chronic idiopathic urticaria, at the recommended dose of 5 mg daily, undesirable effects with Azomyr were reported in 3 % of patients in excess of those treated with placebo. 
V kliničnih preskušanjih pri različnih indikacijah za uporabo zdravila, vključno z alergijskim rinitisom in kronično idiopatsko urtikarijo, so pri priporočenem odmerku 5 mg na dan o neželenih učinkih zdravila Azomyr poročali pri 3 % bolnikov več kot pri tistih, ki so bili zdravljeni s placebom.
How Azomyr works 
Kako deluje zdravilo Azomyr
Azomyr oral solution is also used to relieve the symptoms associated with urticaria (a skin condition caused by an allergy). 
Zdravilo Azomyr se uporablja tudi za lajšanje simptomov urtikarije (težave s kožo zaradi alergije).
How to take Azomyr 
Kako jemati zdravilo Azomyr
Azomyr tablets given at a single daily dose of 7.5 mg did not affect psychomotor performance in clinical trials. 
V kliničnih preskušanjih tablete Azomyr v enem dnevnem odmerku 7,5 mg niso vplivale na psihomotorične sposobnosti bolnikov.
This product contains 1.4 mg of phenylalanine per 2.5 mg dose of Azomyr orodispersible tablet. 
Azomyr orodisperzibilne tablete vsebujejo 1,4 mg fenilalanina na 2,5 mg odmerek zdravila.
Azomyr 0.5 mg/ml oral solution 
Azomyr 0,5 mg/ml peroralna raztopina
Azomyr is an antiallergy medicine that does not make you drowsy. 
Zdravilo Azomyr je zdravilo proti alergiji, ki ne povzroča zaspanosti.
How to store Azomyr oral solution Contents of the pack and other information 
Shranjevanje zdravila Azomyr peroralna raztopina Vsebina pakiranja in dodatne informacije
Clinical efficacy and safety In a multiple dose trial, Azomyr orodispersible tablets were well tolerated. 
V preskušanju večkratnega odmerjanja so bolniki zdravilo Azomyr orodisperzibilne tablete dobro prenašali.
The safety and efficacy of Azomyr 5 mg orodispersible tablets in children below the age of 12 years have not been established. 
Varnost in učinkovitost zdravila Azomyr 5 mg orodisperzibilne tablete pri otrocih, mlajših od 12 let, nista bili dokazani.
What Azomyr looks like and contents of the pack 
Izgled zdravila Azomyr in vsebina pakiranja
If you forget to take Azomyr oral solution 
Če ste prenehali jemati zdravilo Azomyr
What Azomyr contains 
Kaj vsebuje zdravilo Azomyr
In patients with allergic rhinitis, Azomyr was effective in relieving symptoms such as sneezing, nasal discharge and itching, as well as ocular itching, tearing and redness, and itching of palate. 
Pri bolnikih z alergijskim rinitisom zdravilo Azomyr učinkovito lajša simptome, kakor so kihanje, iztok iz nosa in srbenje, pa tudi srbenje oči, solzenje in vnetje očesne veznice ter srbenje ustnega neba.
This product contains 2.9 mg of phenylalanine per 5 mg dose of Azomyr orodispersible tablet. 
Azomyr orodisperzibilne tablete vsebujejo 2,9 mg fenilalanina na 5 mg odmerek zdravila.
What Azomyr orodispersible tablet looks like and contents of the pack 
Izgled zdravila Azomyr orodisperzibilna tableta in vsebina pakiranja
In patients with allergic rhinitis, Azomyr tablets were effective in relieving symptoms such as sneezing, nasal discharge and itching, as well as ocular itching, tearing and redness, and itching of palate. 
Pri bolnikih z alergijskim rinitisom tablete Azomyr učinkovito lajšajo simptome, kakor so kihanje, iztok iz nosa in srbenje, pa tudi srbenje oči, solzenje in vnetje očesne veznice ter srbenje ustnega neba.
Azomyr 5 mg film-coated tablets 
Azomyr 5 mg filmsko obložene tablete
Do not take Azomyr orodispersible tablet - if you are allergic to desloratadine, or any of the other ingredients of this medicine (listed in section 6) or to loratadine. 
Ne uporabljajte zdravila Azomyr orodisperzibilna tableta - če ste alergični na desloratadin ali katero koli sestavino tega zdravila (navedeno v poglavju 6)
Azomyr given at a single daily dose of 7.5 mg did not affect psychomotor performance in clinical trials. 
V kliničnih preskušanjih zdravilo Azomyr v enem dnevnem odmerku 7,5 mg ni vplivalo na psihomotorične sposobnosti bolnikov.
Do not take Azomyr oral solution - if you are allergic to desloratadine, or to any of the other ingredients of this medicine (listed in section 6) or to loratadine. 
Ne uporabljajte zdravila Azomyr - če ste alergični na desloratadin ali katero koli sestavino tega zdravila (navedeno v poglavju 6)
Azomyr oral solution is available in bottles of 30, 50, 60, 100, 120, 150, 225 and 300 ml, with a childproof cap. For all packages except the 150 ml bottle, a measuring spoon is provided, marked for doses of 2.5 ml and 5 ml. 
Azomyr peroralna raztopina je na voljo v stekleničkah po 30, 50, 60, 100, 120, 150, 225 in 300 ml, z zaporko, varno za otroke.
Azomyr 5 mg film-coated tablets desloratadine 
Azomyr 5 mg filmsko obložene tablete desloratadin
What Azomyr orodispersible tablet contains 
Kaj vsebuje zdravilo Azomyr orodisperzibilna tableta
Azomyr 2.5 mg orodispersible tablets desloratadine 
Azomyr 2,5 mg orodisperzibilne tablete desloratadin
Azomyr 2.5 mg orodispersible tablet 
Azomyr 2,5 mg orodisperzibilna tableta
How to store Azomyr 
Shranjevanje zdravila Azomyr
Azomyr orodispersible tablet relieves symptoms associated with allergic rhinitis (inflammation of the nasal passages caused by an allergy, for example, hay fever or allergy to dust mites) in adults, adolescents and children 6 years of age and older. 
Zdravilo Azomyr orodisperzibilna tableta lajša simptome alergijskega rinitisa (vnetje nosnih poti zaradi alergije, na primer seneni nahod ali alergija na pršice) pri odraslih, mladostnikih in otrocih, starih 6 let in več.
Azomyr oral solution relieves symptoms associated with allergic rhinitis (inflammation of the nasal passages caused by an allergy, for example, hay fever or allergy to dust mites) in adults, adolescents and children 1 year of age and older. 
Zdravilo Azomyr peroralna raztopina lajša simptome alergijskega rinitisa (vnetje nosnih poti zaradi alergije, na primer seneni nahod ali alergija na pršice) pri odraslih, mladostnikih in otrocih, starih 1 leto in več.
Azomyr 2.5 mg orodispersible tablets 
Azomyr 2,5 mg orodisperzibilne tablete
Azomyr orodispersible tablet relieves symptoms associated with allergic rhinitis (inflammation of the nasal passages caused by an allergy, for example, hay fever or allergy to dust mites) in adults and adolescents 12 years of age and older. 
Zdravilo Azomyr orodisperzibilna tableta lajša simptome alergijskega rinitisa (vnetje nosnih poti zaradi alergije, na primer seneni nahod ali alergija na pršice) pri odraslih in mladostnikih, starih 12 let in več.
Azomyr relieves symptoms associated with allergic rhinitis (inflammation of the nasal passages caused by an allergy, for example, hay fever or allergy to dust mites) in adults and adolescents 12 years of age and older. 
Zdravilo Azomyr lajša simptome alergijskega rinitisa (vnetje nosnih poti zaradi alergije, na primer seneni nahod ali alergija na pršice) pri odraslih in mladostnikih, starih 12 let in več.
Azomyr 5 mg orodispersible tablet 
Azomyr 5 mg orodisperzibilna tableta
Azomyr 5 mg orodispersible tablets 
Azomyr 5 mg orodisperzibilne tablete
The recommended dose is 2.5 ml (½ of a 5 ml spoonful) of oral solution once a day. 
Priporočeni odmerek zdravila Azomyr je 10 ml (5 mg) peroralne raztopine enkrat na dan.
Azomyr 5 mg orodispersible tablets desloratadine 
Azomyr 5 mg orodisperzibilne tablete desloratadin
How to store Azomyr orodispersible tablet 
Shranjevanje zdravila Azomyr orodisperzibilna tableta
What measures are being taken to ensure the safe and effective use of Ledaga? 
Kateri ukrepi se izvajajo za zagotovitev varne in učinkovite uporabe zdravila Ledaga?
This means that it is similar to a ‘reference medicine' (in this case Caryolysine) containing the same active substance and used for the same purpose. 
To pomeni, da je podobno „referenčnemu zdravilu“ (v tem primeru zdravilu Caryolysine), ki vsebuje enako zdravilno učinkovino in se ga uporablja v enake namene.
Ledaga was effective in 58% of patients (76 patients out of 130) after at least 6 months of treatment compared with 48% of patients (62 out of 130) using the ointment. 
Zdravilo Ledaga je bilo po vsaj šestih mesecih zdravljenja učinkovito pri 58 % (76 od 130) bolnikov v primerjavi z 48 % (62 od 130) bolnikov, ki so uporabljali mazilo.
This is a summary of the European public assessment report (EPAR) for Ledaga. 
To je povzetek evropskega javnega poročila o oceni zdravila (EPAR) za zdravilo Ledaga.
The most common side effects with Ledaga (which may affect more than 1 in 10 people) are dermatitis (skin inflammation with reddening, rash, pain and burning sensation), skin infection and itching. 
Najpogostejši neželeni učinki zdravila Ledaga (ki lahko prizadenejo več kot 1 osebo od 10 ) so dermatitis (vnetje kože z rdečico, izpuščaji, bolečinami in pekočim občutkom), okužba kože in srbenje.
Effectiveness was measured as complete or partial improvement in the ‘CAILS' score, which takes into account different features of the cancer, such as the size and appearance of the skin damage. 
Učinkovitost je bila izmerjena kot popolno ali delno izboljšanje po sestavljeni oceni indeksa resnosti poškodb (CAILS), ki upošteva različne lastnosti raka, kot sta obseg in videz poškodb na koži.
Alkylating agents work by attaching to the DNA of cells while the cells are dividing. 
Alkilirajoče učinkovine delujejo tako, da se pritrdijo na DNK celic, medtem ko se celice delijo.
Treatment should be stopped if patients develop blisters or open sores. 
Zdravljenje je treba prekiniti, če se pri bolnikih razvijejo mehurji ali odprte rane.
What are the risks associated with Ledaga? 
Kakšna so tveganja, povezana z zdravilom Ledaga?
The company that markets Ledaga will supply materials to prevent accidental contact with the medicine, especially in the eye and the inside of the nose and mouth. 
Družba, ki trži zdravilo Ledaga, bo priskrbela potrebščine, ki bodo preprečevale naključne stike z zdravilom, predvsem z očmi in notranjostjo nosu ter ust.
What is Ledaga and what is it used for? 
Kaj je zdravilo Ledaga in za kaj se uporablja?
In addition, a study involving 260 patients found that Ledaga was at least as effective as an ointment containing the same amount of chlormethine. 
Poleg tega je študija, ki je vključevala 260 bolnikov, pokazala, da je zdravilo Ledaga vsaj tako učinkovito kot mazilo, ki vsebuje enako količino klormetina.
What benefits of Ledaga have been shown in studies? 
Kakšne koristi je zdravilo Ledaga izkazalo v študijah?